Cardiovascular Disease

Showing NaN - NaN of 26

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Dyslipidemia, Atherosclerosis, Acute Coronary Syndrome Trial in Dallas (RVX000222, Placebo)

Completed
  • Dyslipidemia
  • +3 more
  • Dallas, Texas
    Covance Clinical Research Unit, Inc.
Nov 1, 2022

Patients With Heart Failure Using HeartLogic

Completed
  • Heart Failure
  • +5 more
  • HeartLogic Sensors
  • Birmingham, Alabama
  • +87 more
Oct 24, 2022

Heart Failure, Anemia, Cardiovascular Disease Trial in Worldwide (Darbepoetin alfa, Placebo)

Completed
  • Heart Failure
  • +4 more
  • Darbepoetin alfa
  • Placebo
  • Birmingham, Alabama
  • +753 more
Oct 31, 2021

Anemia, Cardiovascular Disease Trial in Dallas (EPO, Feraheme)

Terminated
  • Anemia
  • Cardiovascular Disease
  • Dallas, Texas
  • +1 more
Oct 21, 2020

Cardiovascular Disease Trial in Canada, Puerto Rico, United States (Methotrexate, Placebo)

Completed
  • Cardiovascular Disease
  • Birmingham, Alabama
  • +469 more
Jul 23, 2020

Cardiovascular Disease Trial in Worldwide (Dalcetrapib, Placebo)

Terminated
  • Cardiovascular Disease
  • Los Angeles, California
  • +109 more
Mar 20, 2020

Cardiovascular Disease, Diabetes, Type 2 Trial in Worldwide (Dulaglutide, Placebo)

Completed
  • Cardiovascular Disease
  • Diabetes Mellitus, Type 2
  • Mobile, Alabama
  • +300 more
Sep 18, 2019

Cardiovascular Disease, High Cardiovascular Risk, Obesity Trial in Worldwide (Lorcaserin HCl, Placebo)

Completed
  • Cardiovascular Disease
  • +4 more
  • Lorcaserin hydrochloride
  • Placebo
  • Alexander City, Alabama
  • +498 more
Jun 27, 2019

Cardiovascular Disease Trial in Worldwide (bococizumab (PF-04950615), Placebo)

Terminated
  • Cardiovascular Disease
  • bococizumab (PF-04950615)
  • Placebo
  • Athens, Alabama
  • +1595 more
Apr 18, 2019

Cardiovascular Disease, Hypertension, Diabetes Trial in Dallas (Lay Health Promoter (LHP) with maintenance)

Completed
  • Cardiovascular Disease
  • +3 more
  • Lay Health Promoter (LHP) with maintenance
  • Dallas, Texas
    UT Southwestern Medical Center
Feb 8, 2019

Cardiovascular Disease Trial in Worldwide (bococizumab (PF-04950615), Placebo)

Terminated
  • Cardiovascular Disease
  • bococizumab (PF-04950615)
  • Placebo
  • Athens, Alabama
  • +1745 more
Jun 14, 2018

Cardiovascular Disease Trial in Mexico, United States (Febuxostat, Allopurinol)

Completed
  • Cardiovascular Disease
  • Decatur, Georgia
  • +202 more
Jun 12, 2018

Psoriasis, Cardiovascular Disease Trial in United States (Adalimumab (Humira), Placebo Injection, NB-UVB phototherapy)

Completed
  • Psoriasis
  • Cardiovascular Disease
  • Adalimumab (Humira)
  • +2 more
  • Sacramento, California
  • +8 more
Apr 23, 2018

Psoriasis, Cardiovascular Disease Trial in United States (Adalimumab)

Completed
  • Psoriasis
  • Cardiovascular Disease
  • Sacramento, California
  • +8 more
Apr 23, 2018

Cardiovascular Disease Trial in Canada, China, United States (Education)

Completed
  • Cardiovascular Disease
  • Education
  • Long Beach, California
  • +15 more
Aug 28, 2017

Type 2 Diabetes, Cardiovascular Disease Trial in Worldwide (TAK-875, TAK-875 Placebo)

Terminated
  • Type 2 Diabetes
  • Cardiovascular Disease
  • Birmingham, Alabama
  • +587 more
Oct 15, 2015

Cardiovascular Disease Trial in United States (Vascular surgery with best medical treatment, Coronary artery bypass grafting

Completed
  • Cardiovascular Disease
  • Vascular surgery with best medical treatment
  • +2 more
  • Tucson, Arizona
  • +17 more
Jun 25, 2015

Type 2 Diabetes, Cardiovascular Disease Trial in Worldwide (Aliskiren, Placebo)

Terminated
  • Type 2 Diabetes Mellitus
  • Cardiovascular Disease
  • Birmingham, Alabama
  • +777 more
Apr 1, 2014

Type 2 Diabetes, Cardiovascular Disease, Inadequate Glycaemic Control Trial in Worldwide (Dapagliflozin, Placebo)

Completed
  • Type 2 Diabetes Mellitus
  • +2 more
  • Birmingham, Alabama
  • +134 more
Dec 18, 2013

Type 2 Diabetes, Cardiovascular Disease, Hypertension Trial in Worldwide (Dapagliflozin, Placebo)

Completed
  • Type 2 Diabetes Mellitus
  • +3 more
  • Gulf Shores, Alabama
  • +140 more
Sep 24, 2013

What is the Optimal Method for Ischemia Evaluation in WomeN?

Completed
  • Coronary Artery Disease
  • +4 more
    • Tucson, Arizona
    • +42 more
    Jul 31, 2012

    Atherosclerosis, Cardiovascular Disease Trial in Dallas (GW856553)

    Completed
    • Atherosclerosis
    • Cardiovascular Disease
    • Dallas, Texas
      GSK Investigational Site
    May 31, 2012

    Same Day Versus Next Day Discharge: Ambulatory Closure Device

    Completed
    • Cardiovascular Disease
    • discharge vs. overnight stay
    • New York, New York
    • +1 more
    Jul 26, 2011

    Cardiovascular Disease Trial in Dallas (dialysis)

    Unknown status
    • Cardiovascular Disease
    • dialysis
    • Dallas, Texas
      Dallas VA Medical Center
    Feb 24, 2010

    Cardiovascular Disease, Cerebrovascular Accident, Coronary Heart Disease Trial in Worldwide (Atorvastatin)

    Completed
    • Cardiovascular Disease
    • +2 more
    • Alabaster, Alabama
    • +313 more
    May 1, 2007